DOLIVER ADVISORS, LP – BioCryst Pharmaceuticals, Inc. Transaction History
DOLIVER ADVISORS, LP portfolio value:
$1.02M
portfolio value
DOLIVER ADVISORS, LP quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 164K | $12.6 | 81K | |
| Q2 2022 | share | 0.00% | 0 shares | -460K | $10.58 | 81K | |
| Q1 2022 | share | Decrease | -19.00% | -19K shares | -204K | $16.26 | 81K |
| Q4 2021 | share | 0.00% | 0 shares | 84K | $13.79 | 100K | |
| Q3 2021 | share | Increase | 0.00% | 100K shares | 1.43M | $14.37 | 100K |